Zweig-DiMenna Associates’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-105,300	Closed	-$4.3M	–	127
2023 Q1	$4.3M	Sell	105,300 -34,750	-25%	-$1.38M	0.58%	63
2022 Q4	$5.41M	Hold	140,050	–	–	0.79%	49
2022 Q3	$7.45M	Sell	140,050 -24,200	-15%	-$1.35M	1.62%	23
2022 Q2	$9.58M	Sell	164,250 -2,425	-1%	-$159K	1.91%	19
2022 Q1	$12.7M	Sell	166,675 -28,325	-15%	-$1.89M	1.93%	20
2021 Q4	$11.7M	Buy	195,000 +19,962	+11%	+$1.1M	0.95%	46
2021 Q3	$9.8M	Buy	175,038 +2,500	+1%	+$144K	0.69%	61
2021 Q2	$10.5M	Sell	172,538 -10,286	-6%	-$651K	0.65%	67
2021 Q1	$12.8M	Buy	182,824 +44,500	+32%	+$3.18M	0.9%	46
2020 Q4	$8.28M	Buy	138,324 +81,400	+143%	+$4.77M	0.55%	69
2020 Q3	$3.42M	Buy	56,924 +15,000	+36%	+$872K	0.23%	102
2020 Q2	$2.2M	Buy	+41,924	New	+$1.75M	0.23%	91